Stakeholder Intervention at 19th RCEP negotiations round- Mongkon, on behalf of Alternative Agriculture Network and FTA Watch, Thailand.

Civil society’s concerns over inclusion of UPOV 1991 in the RCEP negotiation, given to the trade negotiators of the 16 RCEP negotiating countries during the stakeholder consultation meeting hosted by the RCEP negotiators in Hyderabad, India on July 25, 2917.

My name is Mongkon, on behalf of Alternative Agriculture Network and FTA Watch, Thailand.

Like TPP, RCEP requires countries to be a party of UPOV 1991.  Continue reading

Posted in Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

Stakeholder Intervention at 19th RCEP negotiations round- Kumron from StopDrink Network and FTA Watch, Thailand

Good afternoon. My name is Kumron from StopDrink Network and FTA Watch, Thailand. It is such a long day and also long journey of RCEP negotiation. I’m here to tell you my 2 main concerns.

 

RCEP aim is to reduce tariff among members. This lead to overall price reduction in many imported goods. According to law of demand, when good prices are cheaper, consumption will increase. Given we trade alcohol and tobacco products, their prices will be cheaper.

Continue reading

Posted in Investor state dispute, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

Stakeholder Intervention at 19th RCEP negotiations round- Adv. (Dr.) Albertina Almeida, Advocate and Human Rights Activist, Goa, Member, Asia Pacific Forum on Women, Law and Development (APWLD)

At the outset, I would like to remind you, that we cannot talk of a Comprehensive Economic Partnership without it being inclusive. In the spirit of substantive equality which India’s Constitution makers have envisioned with such foresight, and which the Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW) also emphasises, to be inclusive, both the process and the result must promote equality, promote equal democratic rights, must result in more equitable access to resources, more sustainable income generating opportunities and advance Development Justice for those who are most marginalised in each of these participating countries, and this includes women with their intersecting identities of caste, class, minority, and other axis of marginalisation. India is currently the second most unequal country in the world in terms of the distribution of wealth and gender inequality has been deepening in our country being one of the only countries where the division of labour and income gap is widening. This Agreement will accelerate further these inequalities. Continue reading

Posted in Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

What’s at stake in Hyderabad

By Feroz Ali, The Hindu | July 28, 2017

India must counter Japan’s U.S.-style pressure at the RCEP talks and ensure affordable generic medicines

Leaked texts are like leaked gases — you may never find the one responsible for it, but the mayhem caused by its release is hard to contain. Unsurprisingly, all public discussions on the Regional Comprehensive Economic Partnership (RCEP) are centred around leaked documents. As India negotiates the RCEP — a free trade agreement that looks remarkably similar to the now failed Trans-Pacific Partnership (TPP) but for the absence of the chief protagonist and dissenter, the United States — Japan now appears to be playing the role that the United States is known for: policing the intellectual property (IP) regimes of its trading partners. Unlike the TPP, where India and China were not parties, the RCEP will open two of the world’s fastest-growing economies to new standards of IP protection with some unforeseen consequences.

Continue reading

Posted in Data Exclusivity, IP Rights, IPR, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

No logic in extending length of patents

Granting a longer term for pharmaceutical patents will result in delays in the entry of generic versions and could adversely affect access to medicines

Granting a longer term for drug patents will result in delays in the entry of generic versions and could adversely affect access to affordable medicines. Photo: Bloomberg

 

By Feroz Ali, Live Mint | July 28, 2017

A proposal to further extend the already 20-year-long patent term for pharmaceuticals is on the negotiation table of the Regional Comprehensive Economic Partnership (RCEP). As India negotiates the RCEP, a free trade agreement that can change the intellectual property (IP) landscape of its member countries, this week, we need to look closely at the proposal in the broader context of how the term of protection for IP rights has increased steadily over the years. More so for the generic pharmaceutical companies in India that manufacture patented drugs after the expiry of the patent term. Any extension of the patent term will adversely affect access to the cheaper medicines that they manufacture. Continue reading

Posted in Biologics/Biosimilars, Data Exclusivity, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Pics: HIV community rally against harmful provisions in RCEP

This gallery contains 11 photos.

Gallery | Leave a comment

Stakeholder Intervention at 19th RCEP negotiations round- James Love, Knowledge Ecology International

These are the notes I used when providing the KEI comments at the July 25, 2017 civil society stakeholder forum at the 19th round of the RCEP negotiation.

My name is James Love. I work for Knowledge Ecology International, an NGO that focuses on the social aspects to the production, management and control of knowledge goods. I am also a member of the board of directors of the Union for Affordable Cancer Treatment. Continue reading

Posted in Delinkage, FTA, IPR, Patent, R&D, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment